Department of Physiology University of Medicine and Pharmacy"Iuliu Ha(t)ieganu" Cluj-Napoca 400000 Romania;
Department of Physiology University of Medicine and Pharmacy"Iuliu Ha(t)ieganu" Cluj-Napoca 400000 Romania;
Department of Physiology University of Medicine and Pharmacy"Iuliu Ha(t)ieganu" Cluj-Napoca 400000 Romania;
Department of Physiology University of Medicine and Pharmacy"Iuliu Ha(t)ieganu" Cluj-Napoca 400000 Romania;
Department of Physiology University of Medicine and Pharmacy"Iuliu Ha(t)ieganu" Cluj-Napoca 400000 Romania;
Department of Physiology University of Medicine and Pharmacy"Iuliu Ha(t)ieganu" Cluj-Napoca 400000 Romania;
Department of Physiology University of Medicine and Pharmacy"Iuliu Ha(t)ieganu" Cluj-Napoca 400000 Romania;
Department of Physiology University of Medicine and Pharmacy"Iuliu Ha(t)ieganu" Cluj-Napoca 400000 Romania;
Melanoma; inflammation; COX-2; COX-2 inhibitors; celecoxib;